Susan Hasty, Publisher
Table of Contents . . . March 9th, 1998Non-Subscriber - Summaries Only
Conference Coverage (Blood Safety) - CJD Issues Are Fraught with Uncertainty and Controversy
Conference Coverage (Blood Safety) - Lookback Study Points to Safety of Transfusion
Diagnostics (HIV) - Combination of ELISAs Is Reliable, Cost-Effective
Therapy (Parkinson Disease) - Transplanted Immortalized Dopamine Cells Improved Neurological Deficits In Vivo
Vascular Gene Therapy - Fas Ligand Gene Transfer Inhibits Neointima Formation in Blood Vessels
Blood Safety (HCV) - $200 Million Shortfall in Hepatitis Deal, CBC Reports
Blood Safety (HCV) - Canadian Health Ministry Reports HCV-Tainted Blood Infected 60,000 to 90,000
Creutzfeldt-Jakob Disease - WHO Recommends New Diagnostic Criteria for CJD
Industry News (Joint Venture) - Definitive Agreement Signed To Develop and Market Blood Products
Infection Control - Uganda: Winning the Fight Against AIDS
Testing (Helicobacter Pylori) - FDA 510(k) Submission Announced for Stat-Simple Rapid Whole Blood Test
Therapy (Antiviral) - "Indinavir in Therapy-Experienced HIV Haemophiliac Patients."
Transmission (CJD) - Creutzfeldt-Jakob Disease (CJD) Investigational Lookback Study."
Blood Substitutes - "Absence of Immunogenicity of Diaspirin Cross-Linked Hemoglobin in Humans."
Cytomegalovirus - "Cytomegalovirus Retinitis after Cardiac Transplantation."
Diagnostics (Hemorrhagic Fever) - "Marburg Hemorrhagic Fever: Report of a Case Studied by Immunohistochemistry and Electron Microscopy."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.